Abstract: The invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and associated methods of treating cancer.

Abstract: Compounds of formula (I), formula (I), processes for their production and their use as pharmaceuticals.

Abstract: A stacked AW filter package includes a first substrate stacked on a second substrate. The first substrate has a first AW filter circuit on first surface and a metal layer on a second surface. The second substrate has a second AW filter circuit disposed in a cavity between the metal layer of the first substrate and a third surface of the second substrate. The metal layer is coupled to the second AW filter circuit by a metal interconnect formed in a metallization layer on a side surface of the first substrate. The metal layer provides isolation to reduce cross-talk (e.g., electromagnetic interference) within the stacked AW filter package between the first AW filter circuit and the second AW filter circuit. Including the metal layer in the stacked AW filter package improves signal quality of transmitted and received signals filtered in the first and second AW filter circuits.

Abstract: The present invention relates to compounds of formula (I) processes for their production and their use as pharmaceuticals. The compounds are inhibitors of Casein kinase 1 alpha and/or delta (CSNK1? and/or ?) useful for the treatment of proliferative disorders.

Abstract: Certain aspects of the present disclosure provide a surface acoustic wave (SAW) resonator with piston mode design and electrostatic discharge (ESD) protections. An example electroacoustic device generally includes a piezoelectric material and a first electrode structure disposed above the piezoelectric material. The first electrode structure comprises first electrode fingers arranged within an active region having a first region and a second region. At least one of the first electrode fingers has at least one of a different width or a different height in the first region than in the second region, and the first electrode fingers comprise a first electrode finger that has a width or height in the second region that is less than a corresponding width or height of the at least one of the first electrode fingers in the second region.

Abstract: Aspects of the disclosure relate to devices, wireless communication apparatuses, methods, and circuitry implementing bulk wave suppression in a stacked electroacoustic device. One aspect includes a first substrate comprising a first surface and a second surface, where the second surface is opposite the first surface, a first AW resonator circuit positioned on the first surface of the first substrate, a plurality of elements including a first element, where the plurality of elements are positioned on the second surface of the first substrate, and where the first element is aligned with the first AW resonator circuit, and a second substrate comprising a first surface and a second surface, where the plurality of elements are positioned on the first surface of the second substrate, and where the plurality of elements create a cavity between the first substrate and the second substrate.

Abstract: Compounds of formula (I), process for their production and their use as pharmaceuticals.

Abstract: Aspects of the disclosure relate to wireless communication, and high-frequency filters with resonators configured to systematically modify phase characteristics of an antenna reflection coefficient. One example is a wireless communication apparatus for a multi-band system comprising a frequency band filter circuit having a filter passband that includes a first band of the multi-band system. The frequency band filter circuit comprises a plurality of resonators coupled between an antenna port and a signal port and a resonant structure electrically coupled to the plurality of resonators. The resonant structure has a resonance outside of the first band and a second band of the multi-band system, the resonance being closer to the second band than to the first band.

Abstract: Compounds of formula (I), process for their production and their use as pharmaceuticals.

Abstract: Compounds of formula (I), process for their production and their use as pharmaceuticals.

Abstract: Compounds of formula (I), process for their production and their use as pharmaceuticals.

Abstract: A stacked AW filter package includes a first substrate stacked on a second substrate. The first substrate has a first AW filter circuit on first surface and a metal layer on a second surface. The second substrate has a second AW filter circuit disposed in a cavity between the metal layer of the first substrate and a third surface of the second substrate. The metal layer is coupled to the second AW filter circuit by a metal interconnect formed in a metallization layer on a side surface of the first substrate. The metal layer provides isolation to reduce cross-talk (e.g., electromagnetic interference) within the stacked AW filter package between the first AW filter circuit and the second AW filter circuit. Including the metal layer in the stacked AW filter package improves signal quality of transmitted and received signals filtered in the first and second AW filter circuits.

Abstract: The present invention relates to compounds of formula (I) processes for their production and their use as pharmaceuticals. The compounds are inhibitors of Casein kinase 1 alpha and/or delta (CSNK1? and/or ?) useful for the treatment of proliferative disorders.

Abstract: A housing for receiving an electrical or electronic functional module includes: a first housing element having a first surface section and at least one first connecting section arranged on the first surface section; a second housing element having a second surface section and at least one second connecting section arranged on the second surface section, the first housing element and the second housing element being connectable to each other via the at least one first connecting section and the at least one second connecting section; and an intermediate element arrangeable between the at least one first connecting section and the at least one second connecting section in order to connect the first housing element and the second housing element, the intermediate element having at least one functional device for providing an additional function independent of the connection of the at least one first connecting section.

Abstract: Certain aspects of the present disclosure provide a surface acoustic wave (SAW) resonator with piston mode design and electrostatic discharge (ESD) protections. An example electroacoustic device generally includes a piezoelectric material and a first electrode structure disposed above the piezoelectric material. The first electrode structure comprises first electrode fingers arranged within an active region having a first region and a second region. At least one of the first electrode fingers has at least one of a different width or a different height in the first region than in the second region, and the first electrode fingers comprise a first electrode finger that has a width or height in the second region that is less than a corresponding width or height of the at least one of the first electrode fingers in the second region.

Abstract: Compounds of formula (I) processes for their production and their use as pharmaceuticals.

Abstract: Aspects of the disclosure relate to wireless communication, and high-frequency filters with resonators configured to systematically modify phase characteristics of an antenna reflection coefficient. One example is a wireless communication apparatus for a multi-band system comprising a frequency band filter circuit having a filter passband that includes a first band of the multi-band system. The frequency band filter circuit comprises a plurality of resonators coupled between an antenna port and a signal port and a resonant structure electrically coupled to the plurality of resonators. The resonant structure has a resonance outside of the first band and a second band of the multi-band system, the resonance being closer to the second band than to the first band.

Abstract: A modular system for producing an electronic device includes: a housing, which forms an accommodating space; a printed circuit board which is insertable along an insertion direction into the accommodating space of the housing and, in a mounting position, is accommodated in the accommodating space; and a plurality of attachment parts, which are connectable to the printed circuit board and which, when viewed along the insertion direction, each have a division corresponding to a predetermined smallest dividing unit or an integral multiple of the predetermined smallest dividing unit. Each attachment part has a first guide device for guiding on a second guide device of the housing and a combination of attachment parts is connectable to the printed circuit board in a manner arranged next to one another along the insertion direction such that when the printed circuit board is inserted into the accommodating space, the combination is guided.

Abstract: A modular system for producing an electronic device includes: a housing, which forms an accommodating space; a printed circuit board which is insertable along an insertion direction into the accommodating space of the housing and, in a mounting position, is accommodated in the accommodating space; and a plurality of attachment parts, which are connectable to the printed circuit board and which, when viewed along the insertion direction, each have a division corresponding to a predetermined smallest dividing unit or an integral multiple of the predetermined smallest dividing unit. Each attachment part has a first guide device for guiding on a second guide device of the housing and a combination of attachment parts is connectable to the printed circuit board in a manner arranged next to one another along the insertion direction such that when the printed circuit board is inserted into the accommodating space, the combination is guided.

Abstract: The present invention covers heteroarylbenzimidazole compounds of general formula (I) in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative and/or inflammatory disorders, as a sole agent or in combination with other active ingredients.